Glaukos EBITDA Margin 2014-2025 | GKOS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Glaukos (GKOS) over the last 10 years. The current EBITDA margin for Glaukos as of September 30, 2025 is .
| Glaukos EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.47B | $-0.05B | -11.49% |
| 2025-06-30 | $0.43B | $-0.06B | -14.32% |
| 2025-03-31 | $0.41B | $-0.07B | -17.04% |
| 2024-12-31 | $0.38B | $-0.09B | -22.40% |
| 2024-09-30 | $0.36B | $-0.09B | -25.48% |
| 2024-06-30 | $0.34B | $-0.10B | -28.95% |
| 2024-03-31 | $0.33B | $-0.10B | -29.75% |
| 2023-12-31 | $0.31B | $-0.09B | -28.66% |
| 2023-09-30 | $0.30B | $-0.09B | -29.04% |
| 2023-06-30 | $0.30B | $-0.08B | -26.35% |
| 2023-03-31 | $0.29B | $-0.09B | -29.76% |
| 2022-12-31 | $0.28B | $-0.04B | -15.55% |
| 2022-09-30 | $0.29B | $-0.03B | -10.18% |
| 2022-06-30 | $0.29B | $0.00B | 1.04% |
| 2022-03-31 | $0.29B | $0.03B | 8.50% |
| 2021-12-31 | $0.29B | $0.00B | 1.02% |
| 2021-09-30 | $0.29B | $0.04B | 12.59% |
| 2021-06-30 | $0.28B | $0.02B | 5.63% |
| 2021-03-31 | $0.24B | $-0.02B | -7.14% |
| 2020-12-31 | $0.23B | $-0.06B | -25.78% |
| 2020-09-30 | $0.22B | $-0.10B | -47.71% |
| 2020-06-30 | $0.21B | $-0.11B | -53.77% |
| 2020-03-31 | $0.24B | $-0.08B | -33.47% |
| 2019-12-31 | $0.24B | $-0.04B | -15.55% |
| 2019-09-30 | $0.23B | $-0.01B | -5.75% |
| 2019-06-30 | $0.21B | $-0.01B | -3.32% |
| 2019-03-31 | $0.20B | $-0.01B | -3.08% |
| 2018-12-31 | $0.18B | $-0.01B | -3.87% |
| 2018-09-30 | $0.17B | $-0.01B | -4.73% |
| 2018-06-30 | $0.17B | $0.00B | -0.61% |
| 2018-03-31 | $0.16B | 0 | 0.00% |
| 2017-12-31 | $0.16B | $0.00B | 1.89% |
| 2017-09-30 | $0.15B | $0.00B | 2.00% |
| 2017-06-30 | $0.14B | $0.00B | 2.14% |
| 2017-03-31 | $0.13B | $0.01B | 6.25% |
| 2016-12-31 | $0.12B | $0.01B | 7.83% |
| 2016-09-30 | $0.10B | $0.01B | 5.88% |
| 2016-06-30 | $0.09B | $0.00B | 3.30% |
| 2016-03-31 | $0.08B | $0.00B | -5.00% |
| 2015-12-31 | $0.07B | $-0.01B | -8.33% |
| 2015-09-30 | $0.07B | $-0.01B | -13.64% |
| 2015-06-30 | $0.06B | $-0.01B | -15.25% |
| 2015-03-31 | $0.05B | $-0.01B | -11.54% |
| 2014-12-31 | $0.05B | $-0.01B | -20.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.131B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $191.543B | 22.29 |
| Intuitive Surgical (ISRG) | United States | $169.965B | 65.56 |
| IDEXX Laboratories (IDXX) | United States | $49.284B | 47.22 |
| Edwards Lifesciences (EW) | United States | $44.358B | 29.86 |
| Alcon (ALC) | Switzerland | $38.852B | 26.18 |
| IQVIA Holdings (IQV) | United States | $28.755B | 15.53 |
| Mettler-Toledo (MTD) | United States | $27.600B | 31.74 |
| DexCom (DXCM) | United States | $25.382B | 31.14 |
| STERIS (STE) | Ireland | $23.952B | 24.23 |
| Waters (WAT) | United States | $19.045B | 24.36 |
| Coloplast (CLPBY) | Denmark | $17.466B | 26.72 |
| Hologic (HOLX) | United States | $16.723B | 17.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.525B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.179B | 11.76 |
| Penumbra (PEN) | United States | $13.265B | 93.31 |
| Globus Medical (GMED) | United States | $11.673B | 24.50 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.142B | 22.89 |
| Sysmex ADR (SSMXY) | Japan | $5.930B | 19.62 |
| Teleflex (TFX) | United States | $4.620B | 7.36 |
| TransMedics (TMDX) | United States | $4.392B | 52.03 |
| LivaNova (LIVN) | United Kingdom | $3.490B | 18.85 |
| Integer Holdings (ITGR) | United States | $2.991B | 14.04 |
| Veracyte (VCYT) | United States | $2.779B | 31.67 |
| Elekta AB (EKTAY) | Sweden | $2.267B | 21.21 |
| Nihon Kohden (NHNKY) | Japan | $1.968B | 21.72 |
| Alphatec Holdings (ATEC) | United States | $1.946B | 0.00 |
| Artivion (AORT) | United States | $1.926B | 64.52 |
| UFP Technologies (UFPT) | United States | $1.907B | 25.18 |
| Pulse Biosciences (PLSE) | United States | $1.586B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.570B | 0.00 |
| AxoGen (AXGN) | United States | $1.504B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.05 |
| Tandem Diabetes Care (TNDM) | United States | $1.267B | 0.00 |
| OPKO Health (OPK) | United States | $0.929B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.842B | 4.56 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.685B | 13.67 |
| SiBone (SIBN) | United States | $0.650B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.613B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.597B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.36 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.525B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.489B | 12.74 |
| NeuroPace (NPCE) | United States | $0.483B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.455B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.371B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.322B | 53.65 |
| RxSight (RXST) | United States | $0.321B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.285B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.282B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.234B | 0.00 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.178B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.168B | 0.00 |
| Inogen (INGN) | United States | $0.157B | 0.00 |
| CVRx (CVRX) | United States | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.140B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.131B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.121B | 0.00 |
| Neuronetics (STIM) | United States | $0.108B | 0.00 |
| Hyperfine (HYPR) | United States | $0.106B | 0.00 |
| Solana (HSDT) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| DarioHealth (DRIO) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.065B | 0.00 |
| Accuray (ARAY) | United States | $0.061B | 0.00 |
| Spectral AI (MDAI) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.015B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |